TABLE 2.
Comparison of FTO rs9939609 polymorphism between healthy controls and the sarcopenia group
| Group | Genotype (%) | Allele (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| TT | AT | AA | χ 2 | p 1 | A | T | χ 2 | p 2 | |
| Sarcopenia | 54 (67.5) | 23 (28.75) | 3 (3.75) | 7.343 | 0.024 | 29 (18.125) | 131 (81.875) | 6.174 | 0.013 |
| S‐Male | 28 (70.0) | 10 (25.0) | 2 (5.0) | 2.198 | 0.370 | 14 (17.5) | 66 (82.5) | 1.345 | 0.246 |
| S‐Female | 26 (65.0) | 13 (32.5) | 1 (2.5) | 6.143 | 0.046 | 15 (18.75) | 65 (81.25) | 5.375 | 0.020 |
| Control | 37 (46.25) | 38 (47.5) | 5 (6.25) | — | — | 48 (30.0) | 112 (70.0) | — | — |
| C‐Male | 22 (55.0) | 16 (40.0) | 2 (5.0) | — | — | 20 (25.0) | 60 (75.0) | — | — |
| C‐Female | 15 (37.5) | 22 (55.0) | 3 (7.5) | — | — | 28 (35.0) | 52 (65.0) | — | — |